Journal of Pediatric Nursing
Volume 24, Issue 3 , Pages 173-178 , June 2009

The Genetic Profile and Monitoring of Acute Lymphoblastic Leukemia in Children and Adolescents

References 

  1. Avet-Loiseau H, Mechinaud F, Harousseau JL. Clonal hematologic disorders in Down syndrome. A review. Journal of Pediatric Hematology/Oncology. 1995;17:19–24
  2. Biondi A, Cimino G, Pieters R, Pui CH. Biological and therapeutic aspects of infant leukemia. Blood. 2000;96:24–33
  3. Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. Journal of Clinical Oncology. 2003;21:774–780
  4. Campana D, Van dongen JJM, Pui CH. Minimal residual disease. Childhood leukemias. In:  Pui CH editors. Childhood leukemias. UK: Cambridge University Press; 1999;p. 413–439
  5. Coustan-Smith E, Ribeiro RC, Stow P, Zhou Y, Pui CH, Rivera GK, et al. A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood. 2006;108:97–102
  6. Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. 2000;96:2691–2696
  7. Ernst P, Wang J, Korsmeyer SJ. The role of MLL in hematopoiesis and leukemia. Current Opinion in Hematology. 2002;9:282–287
  8. Evans WE, McLeod HL. Pharmacogenomics—drug disposition, drug targets, and side effects. New England Journal of Medicine. 2003;348:538–549
  9. Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review. Cancer. 1997;80:1717–1726
  10. Jenkins J, Calzone K, Badzek L, Constantin C, Debisette A, Feetham S, et al. Essential nursing competencies and curriculum guidelines for genetics and genomics. Silver Spring, MD: American Nurses Association; 2005;Retrieved from http://www.geonme.gov
  11. Le D, Shannon K, Lange BJ. Heritable predispositions to childhood hematological malignancies. In:  Pui CH editors. Childhood leukemias. New York, NY: Cambridge University Press; 2006;p. 362–387
  12. Look AT, Roberson PK, Williams DL, Rivera G, Bowman WP, Pui CH, et al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood. 1985;65:1079–1086
  13. McLeod HL, Krynetski EY, Relling MV, Evans WE. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia. 2000;14:567–572
  14. Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia—current status and future perspectives. Lancet Oncology. 2001;2:597–607
  15. Pui CH, Evans WE. Acute lymphoblastic leukemia. New England Journal of Medicine. 1998;339:605–615
  16. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. New England Journal of Medicine. 2006;354:166–178
  17. Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 2002;359:1909–1915
  18. Pui CH, Relling MV, Sandlund JT, Downing JR, Campana D, Evans WE. Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Annals of Hematology. 2004;83(Suppl 1):S124–S126
  19. Pui CH, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. Journal of the American Medical Association. 2003;290:2001–2007
  20. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993;81:2237–2251
  21. In:  Ries LAG,  Harkins D,  Krapcho M,  Mariotto A,  Miller BA,  Feuer EJ, et al. editor. SEER cancer statistics review, 1975–2003. Bethesda, MD: National Cancer Institute; 2006;http://seer.cancer.gov/csr/1975_2003/based on November 2005 SEER data submission, accessed February, 2007
  22. Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. Journal of the National Cancer Institute. 1999;91:2001–2008
  23. Relling MV, Pui CH, Sandlund JT, Rivera GK, Hancock ML, Boyett JM, et al. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet. 2000;356:285–290
  24. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, et al. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet. 1991;337:61–66
  25. Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005;105:4752–4758
  26. Sandlund JT, Harrison PL, Rivera G, Behm FG, Head D, Boyett J, et al. Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia. Blood. 2002;100:43–47
  27. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology. 1996;14:18–24
  28. Society AC. What are the key statistics about childhood leukemia. Retrieved February 13, 2007, from www.cancer.org2007;
  29. Taub JW, Konrad MA, Ge Y, Naber JM, Scott JS, Matherly LH, et al. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood. 2002;99:2992–2996
  30. Weinshiboum R. Inheritance and drug response. New England Journal of Medicine. 2003;529–537
  31. Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet. 1999;354:1499–1503
  32. Williams DL, Tsiatis A, Brodeur GM, Look AT, Melvin SL, Bowman WP, et al. Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood. 1982;60:864–871

PII: S0882-5963(08)00213-3

doi: 10.1016/j.pedn.2008.04.010

Journal of Pediatric Nursing
Volume 24, Issue 3 , Pages 173-178 , June 2009

Article Tools